Law360 (January 16, 2020, 5:40 PM EST) -- In late December 2019, the U.S. Food and Drug Administration, an agency operating within the U.S. Department of Health and Human Services, issued two documents — a proposed rule and a draft guidance — intended to establish two pathways for drug importation. The U.S. Department of Health and Human Services previewed these approaches in its Safe Importation Action Plan last July.
These proposed pathways are broadly, if not necessarily effectively, aimed at reducing U.S. drug prices in two different ways.
The proposed rule sets out a means by which states and certain other nonfederal governmental entities would be permitted to import...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!